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ABSTRACT
Objective Non-oxidative metabolism of ethanol (NOME)
produces fatty acid ethyl esters (FAEEs) via carboxylester
lipase (CEL) and other enzyme action implicated in
mitochondrial injury and acute pancreatitis (AP). This study
investigated the relative importance of oxidative and non-
oxidative pathways in mitochondrial dysfunction, pancreatic
damage and development of alcoholic AP, and whether
deleterious effects of NOME are preventable.
Design Intracellular calcium ([Ca2+]C), NAD(P)H,
mitochondrial membrane potential and activation of
apoptotic and necrotic cell death pathways were examined
in isolated pancreatic acinar cells in response to ethanol
and/or palmitoleic acid (POA) in the presence or absence of
4-methylpyrazole (4-MP) to inhibit oxidative metabolism.
A novel in vivo model of alcoholic AP induced by
intraperitoneal administration of ethanol and POA was
developed to assess the effects of manipulating alcohol
metabolism.
Results Inhibition of OME with 4-MP converted
predominantly transient [Ca2+]C rises induced by low
ethanol/POA combination to sustained elevations, with
concurrent mitochondrial depolarisation, fall of NAD(P)H
and cellular necrosis in vitro. All effects were prevented by
3-benzyl-6-chloro-2-pyrone (3-BCP), a CEL inhibitor. 3-BCP
also signiﬁcantly inhibited rises of pancreatic FAEE in vivo
and ameliorated acute pancreatic damage and
inﬂammation induced by administration of ethanol and
POA to mice.
Conclusions A combination of low ethanol and fatty
acid that did not exert deleterious effects per se became
toxic when oxidative metabolism was inhibited. The in vitro
and in vivo damage was markedly inhibited by blockade of
CEL, indicating the potential for development of speciﬁc
therapy for treatment of alcoholic AP via inhibition of FAEE
generation.
INTRODUCTION
In recent decades there has been a marked eleva-
tion in alcohol consumption mirrored by a dra-
matic increase in the incidence of acute pancreatitis
(AP). Approximately 20% of affected individuals
develop extensive disease characterised by signiﬁ-
cant pancreatic necrosis and systemic inﬂammation,
which may lead to multiple organ failure and
death. Our understanding of the pathogenesis of
alcoholic AP remains incomplete and currently no
speciﬁc therapy exists.
The exocrine pancreas uses both oxidative and non-
oxidative metabolism of ethanol (OME and NOME,
respectively) to degrade alcohol, the latter combining
ethanol with fatty acids to yield lipophilic fatty acid
ethyl esters (FAEEs).1 A seminal study showed that
FAEEs accumulated in the pancreas of patients
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Signiﬁcance of this study
What is already known about this subject?
▸ Acute alcoholic pancreatitis can be a severe
and life-threatening disease, which currently
lacks a clear target and speciﬁc therapy.
▸ Both oxidative and non-oxidative ethanol
metabolites have been implicated in
ethanol-mediated damage of the exocrine
pancreas, although their relative contributions
to pancreatic toxicity remain unclear.
▸ Increasing evidence has implicated
mitochondrial dysfunction as a key event in the
pathophysiology of acute pancreatitis.
▸ Currently there is no convenient and reliable in
vivo experimental model of alcoholic acute
pancreatitis to test potential therapies.
What are the new ﬁndings?
▸ A new model of alcoholic acute pancreatitis
has been developed.
▸ Promotion of non-oxidative ethanol metabolism
via suppression of the oxidative pathway
exacerbated ethanol-induced Ca2+-dependent
mitochondrial dysfunction and toxicity in vitro
and acute pancreatitis in vivo.
▸ Non-oxidative ethanol metabolites localised to
mitochondria of pancreatic acinar cells and
underwent hydrolysis to release free fatty acids.
▸ Pharmacological inhibition of carboxylester
lipase (CEL) prevented fatty acid ethyl ester
formation and ameliorated in vitro exocrine
pancreatic damage and in vivo acute
pancreatitis induced by fat and ethanol.
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following acute alcohol intoxication, in contrast to other organs
commonly damaged by alcohol.2 The balance between OME and
NOME may be pivotal in determining toxic effects of excess
alcohol. For example, blockade of OME by 4-methylpyrazole
(4-MP) increased pancreatic FAEE levels of rats in response to
ethanol, resulting in organ damage and inﬂammation.3
The generation of FAEEs occurs via diverse FAEE synthase
enzymes4 that include carboxylester lipase (CEL; E.C.3.1.1.13),
also known as bile salt-activated lipase,5 inhibited by
3-benzyl-6-chloro-2-pyrone (3-BCP).6 CEL is synthesised by
pancreatic acinar cells (PACs), stored in zymogen granules, and
secreted upon hormonal stimulation.7 Long-term ethanol
feeding increased pancreatic CEL in rats,8 while high FAEE con-
centrations remain in the serum of patients after ethanol inges-
tion,9 persisting for up to 99 h in heavy drinkers.10 Raised
levels (>5× control) occur in the serum of patients with acute
interstitial or necrotising pancreatitis.11
We previously demonstrated that FAEEs induced toxic sustained
[Ca2+]C elevations in PACs that led to necrosis.
12 Mitochondrial
dysfunction was central to damage; Ca2+ overload caused loss of
membrane potential (ΔψM) and consequent ATP fall, which
impaired [Ca2+]C homeostasis. Supply of ATP to the cell via patch-
pipette inhibited development of toxic [Ca2+]C elevations and
necrosis induced by FAEEs13 and bile acids.14 Nevertheless, supply
of ATP to stressed cells is unlikely to be a viable strategy for preven-
tion of alcohol-induced toxicity in a clinical setting and alternative
approaches are necessary.
This study has investigated whether manipulation of alcohol
metabolic pathways may inﬂuence toxicity in vitro and the devel-
opment of AP in vivo, and if inhibition of CEL with 3-BCP could
prevent deleterious effects. Using molecular modelling, we demon-
strate the likely mechanism of CEL-mediated FAEE generation and
mode of 3-BCP inhibition. Our ﬁndings show that NOME promo-
tion, in response to low ethanol/palmitoleic acid (POA) with con-
current OME inhibition, induced Ca2+-dependent mitochondrial
dysfunction and PAC necrosis. Furthermore, we have developed a
novel experimental model of alcoholic AP based on the combin-
ation of ethanol and POA to induce acute exocrine pancreatic
damage and systemic inﬂammation. Both in vitro and in vivo dele-
terious effects of ethanol/POA associated with promotion of
NOME were ameliorated by CEL inhibition, suggesting potential
for therapeutic intervention in alcoholic AP.
MATERIALS AND METHODS
Cell preparation and solutions
Isolated PACs from adult CD1 mice were prepared as previously
described.13 Experiments were performed at room temperature
unless otherwise indicated. Extracellular solution contained
(mM): 140 NaCl, 4.7 KCl, 1.13 MgCl2, 1 CaCl2, 10 D-glucose,
10 HEPES (adjusted to pH 7.35 using NaOH).
Measurements of [Ca2+]C, ΔψM and NAD(P)H
Confocal imaging was performed using a Zeiss LSM510 system
(Jena GmbH, Germany) at 35°C. Cells were loaded with Fluo
4-AM (3 μM; excitation 488 nm, emission 505–550 nm) or tetra-
methyl rhodamine methyl ester (TMRM, 100 nM; excitation
488 nm, emission >550 nm) to measure [Ca2+]C and ΔψM, respect-
ively, and mitochondrial metabolism (NAD(P)H autoﬂuorescence;
excitation 363 nm, emission 390–450 nm) assessed as described.13
Image analysis was performed using AIM V.4.2 or Zen2009 soft-
ware. Ethanol (10 mM), POA (20 mM), 4-MP (100 mM) and 3-BCP
(10 mM) were applied alone or in combination for 10 min, after
which the protonophore carbonyl cyanide 3-chlorophenylhydrazone
(CCCP, 10 mM) was added to induce complete mitochondrial
depolarisation. Measurements are expressed as changes from basal
ﬂuorescence (F/F0 ratio, ‘n’ represents number of cells).
Detection of apoptotic and necrotic cell death
pathway activation
Apoptotic cell death pathway activation was detected using rhoda-
mine 110-aspartic acid amide (20 μM: excitation 488 nm, emission
505–550 nm), necrotic cell death pathway activation using propi-
dium iodide (PI, 1 mM: excitation 488 nm, emission 630–693 nm)
and total cell count with nuclear Hoechst 33342 (10 mg/mL:
excitation 364 nm, emission 405–450 nm) as described.14 Separate
cell aliquots from each preparation were treated (30 min) with
either (i) ethanol (10 mM), (ii) POA (20 mM), (iii) 4-MP (100 mM)
or (iv) 3-BCP (10 mM) or combinations to differentially modulate
OME and NOME. Counts were made of 30 separate ﬁelds from
each experiment, repeated in triplicate or more.
Immunoﬂuorescence
Intact pancreatic lobules or isolated acinar cells were ﬁxed in
4% paraformaldehyde for 30 min, permeabilised with 0.2%
Triton X-100 and blocked with 1% BSA/10% goat serum. CEL
and mitochondria were localised using anti-bile salt-activated
lipase antibody and mitochondrial anti-peptidyl-prolyl cis-trans
isomerase antibody, respectively (both 1:200, Abcam,
Cambridge UK). Secondary antibodies were conjugated with
Alexa 488 or Alexa 546, used at a dilution of 1:1000. Nuclei
were stained with Hoechst 33342 (10 mg/mL, Invitrogen). CEL
antibody speciﬁcity was conﬁrmed by Western blot (see online
supplementary ﬁgure S2B).
Patch-clamp current recording
Patch-clamp (whole-cell conﬁguration) was used to record
Ca2+-activated Cl− currents (IClCa) as described.
13
Patch-pipettes (2–3 MΩ) were ﬁlled with intracellular solution
(mM): 140 KCl; 1.5 MgCl2; 2 MgATP; 10 HEPES; 0.1 EGTA,
pH 7.2. Currents were sampled at 10 KHz (EPC8 ampliﬁer,
HEKA, Lambrecht, Pfalz, Germany) with membrane voltage
clamped at −30 mV. Changes of IClCa, NAD(P)H and ﬂuores-
cein (excitation 488 nm, emission 505–550 nm) were recorded,
before and after exposure to POA-Fluor (20 mM: in pipette
solution).
In vivo model of FAEE-AP
To establish FAEE-induced AP (FAEE-AP), adult CD1 mice
received two intraperitoneal injections of ethanol (1.35 g/kg)
and POA (150 mg/kg) at 1 h intervals. 200 mL normal saline
was injected immediately prior to ethanol/POA injections to
Signiﬁcance of this study
How might it impact on clinical practice in the
foreseeable future?
▸ New insights into the underlying pathology of acute
alcoholic pancreatitis reveal a speciﬁc enzyme target (CEL)
that may be inhibited to ameliorate ethanol-induced injury.
▸ Elucidation of the molecular basis of non-oxidative ethanol
metabolism mediated by CEL and inhibition by
3-benzyl-6-chloro-2-pyrone (3-BCP) will facilitate rational
design of novel therapeutic compounds that may now be
evaluated using a convenient and reliable experimental
model of acute alcoholic pancreatitis.
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avoid potential local damage by ethanol to peritoneal organs
at the injection site. Control adult CD1 mice received either
saline, ethanol (1.35 g/kg) or POA (150 mg/kg). In treatment
groups, mice also received 10 mg/kg 4-MP or 30 mg/kg 3-BCP
simultaneously with the ﬁrst injection of ethanol/POA.
Animals were sacriﬁced at 24 h after the ﬁrst injection.
Histological assessment of damage was performed after H&E
staining of ﬁxed pancreatic slices (5 mm thickness); 10 random
ﬁelds per slide from all animal groups were graded by two
independent, blinded observers according to severity and
extent of oedema, inﬂammatory cell inﬁltration and acinar
necrosis as previously described.15 Further details of FAEE-AP
model characterisation are included in online supplementary
materials and methods.
Computational protein-ligand docking studies of POA and 3-BCP
Three-dimensional structures of ligands (POA and 3-BCP) were
constructed (ChemDraw; V.11.0) and energy minimised. The X-ray
crystallographic co-ordinates of human CEL (pdb 1F6W) were
downloaded from RCSPB Protein Database and used for docking
procedures. Molegro Virtual Docker (MVDV.3) was used to predict
ligand binding mode in the protein active site. MolDock optimiser
algorithms were used with a maximum of 10 runs and 10 000 itera-
tions per ligand. A maximum of ﬁve poses were returned per ligand
in which similar poses were clustered.16 The top-ranked pose for
each ligand was assigned with respect to afﬁnity (hydrogen bond
and other residue interactions, which may contribute to stability in
the active site). The ligand-protein interactions were visualised using
Molegro Molecular Viewer (V.2.2).
Statistical analysis
Statistical analysis of variance was performed using Origin 8.5.
A value of p<0.05 was considered signiﬁcant.
Chemicals
Fluo 4-AM, TMRM, secondary antibodies, Hoechst 33342 and
R110-aspartic acid amide were purchased from Molecular
Probes (Eugene, Oregon, USA). POA-Fluor was synthesised by
Dr M Jaffar as described (see online supplementary methods
and ﬁgure S1) and 3-BCP by Dr B S Kaphalia.17 All other che-
micals were purchased from Sigma (Gillingham, UK).
RESULTS
Inhibition of OME transforms transient [Ca2+]C signals
induced by ethanol and POA to sustained elevations:
protective effects of 3-BCP
In PACs, application of ethanol (10 mM) with POA (20 mM) pro-
duced predominantly transient [Ca2+]C elevations (32 of 52 cells,
61.5%), with sustained signals observed in only 23.1% (12 of 52
cells, ﬁgure 1A,B). The OME inhibitor 4-MP produced no or
minimal effects on [Ca2+]C per se, but greatly potentiated ethanol/
POA action, increasing the proportion of sustained [Ca2+]C eleva-
tions to 65.5% (ﬁgure 1B inset). Addition of 3-BCP (10 mM),
which produced no effects on resting [Ca2+]C alone (see online
supplementary ﬁgure S7A), completely blocked the increase in sus-
tained [Ca2+]C elevations induced by ethanol/POA/4-MP (ﬁgure
1B). The inhibitory effects of 3-BCP were speciﬁc to ethanol/POA
mediated changes, since oscillatory or sustained [Ca2+]C elevations
induced by 10 pM and 10 nM cholecystokinin, respectively, were
unaffected (see online supplementary ﬁgure S7B,C).
Inhibition of OME exacerbates loss of Δψm and fall
of NAD(P)H induced by EtOH and POA: protective effects
of 3-BCP
A combination of ethanol (10 mM) and POA (20 mM) induced
a gradual mitochondrial depolarisation in PACs. Addition of
the protonophore CCCP (10 mM) after ethanol/POA caused a
further loss of ﬂuorescence as mitochondria became fully depo-
larised (ﬁgure 2A,B). In the additional presence of 4-MP, mito-
chondrial depolarisation induced by low ethanol/POA was
potentiated, whereas 4-MP alone did not alter ΔψM. A pro-
found reduction of NAD(P)H autoﬂuorescence in the mito-
chondrial perigranular region was associated with the loss of
ΔψM, indicative of mitochondrial inhibition (ﬁgure 2C),
14 an
effect more rapid in onset when OME was inhibited (data not
shown). 3-BCP (10 mM), which produced no effects on ΔψM
or NAD(P)H levels alone (see online supplementary ﬁgure
S8B,D), completely blocked the depolarisation and fall in NAD
(P)H induced by low ethanol/POA/4-MP, although further
Figure 1 Effects of ethanol (EtOH), palmitoleic acid (POA),
4-methylpyrazole (4-MP) and 3-benzyl-6-chloro-2-pyrone (3-BCP) on
[Ca2+]C in pancreatic acinar cells. (A) Typical ﬂuorescence images
showing changes of [Ca2+]C (Fluo4, green) before (t=120 s) and after
(t=800 s) application of combinations of ethanol (10 mmol/L), POA
(20 μmol/L), 4-MP (100 μmol/L) and 3-BCP (10 μmol/L). Addition of
ethanol/POA/4-MP caused sustained elevation of [Ca2+]c seen at 800 s.
(B) Combination of ethanol/POA (wine) induced predominantly
oscillatory increases of [Ca2+]C, while additional presence of 4-MP
(100 μmol/L) promoted a shift towards sustained increases (red); 4-MP
alone was without effect (blue). The addition of 3-BCP abolished
sustained rises induced by ethanol/POA/4-MP (cyan). Cumulative data
expressed as percentage of cells exhibiting sustained rises (inset)
(F/F0=>1.5) at 800 s (total n=159 cells).
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addition of CCCP depolarised the mitochondria fully, indicat-
ing that organellar integrity had not been compromised by the
ethanol/POA/4-MP combination. A partial decrease in intracel-
lular ATP levels in response to a combination of ethanol
(10 mM) and POA (20 mM) was inhibited by 3-BCP, which did
not alter basal levels per se (see online supplementary
ﬁgure 8E,F). Further addition of CCCP caused a maximal
depletion, as shown previously.13
Mitochondrial activation of an FAEE probe induces Ca2+-activated
Cl− currents (IClCa) and mitochondrial inhibition
Previous biochemical work in cardiomyocytes suggested that
FAEEs preferentially accumulate in mitochondria where they are
hydrolysed to fatty acids, which uncouple oxidative phosphoryl-
ation.18 Experiments were performed using a novel probe,
POA-Fluor, composed of ﬂuorescein linked to POA via an ester
linkage, analogous to that of FAEEs. Although POA-Fluor was
non-ﬂuorescent, when administered to the PAC interior via a
patch-pipette, cleavage of the probe caused a ﬂuorescence
increase as ﬂuorescein and POA were released (ﬁgure 3A).
Inward IClCa developed following probe activation, composed
of initial transients that gradually became superimposed on a
Figure 3 Mitochondrial localisation and activation of fatty acid ethyl
ester probe (palmitoleic acid (POA)-Fluor) in pancreatic acinar cells.
(A) Light-transmitted and ﬂuorescent images of acinar cell doublet
(inset) at time of membrane rupture (breakthrough) show localised
ﬂuorescence at patch-pipette tip as POA-Fluor activation by hydrolases
released ﬂuorescein. Time-dependent ﬂuorescence rise (green) was
associated with inward Ca2+-activated Cl− currents (IClCa), whereas no
ﬂuorescence was detected in the adjacent cell. (B) Light-transmitted
and ﬂuorescence images, and (C) subcellular regions of interest show
predominantly mitochondrial distribution of ﬂuorescence (ﬂuorescein:
NAD(P)H co-localisation), consistent with mitochondrial probe
activation. [Ca2+]C levels increased over time (sustained inward IClCa
with superimposed transients), accompanied by a concomitant decrease
of NAD(P)H (not seen in non-patched, adjacent cell), consistent with
fatty acid-induced mitochondrial inhibition.
Figure 2 Effects of ethanol (EtOH), palmitoleic acid (POA),
4-methylpyrazole (4-MP) and 3-benzyl-6-chloro-2-pyrone (3-BCP) on
mitochondrial membrane potential (ΔψM) in pancreatic acinar cells.
(A) Typical ﬂuorescence (glow) images showing progressive loss (six
images, left) or maintenance (two images, right) of ΔψM to ethanol/
POA/4-MP combination in absence (left), or presence (right) of 3-BCP.
Complete mitochondrial depolarisation induced by carbonyl cyanide
3-chlorophenylhydrazone (CCCP;10 μmol/L) is seen at 900 s. (B) Graph
showing ethanol/POA-induced loss of ΔψM (n=39), exacerbated by
4-MP (n=44). 4-MP alone was without effect (n=23). 3-BCP abolished
effects of ethanol/POA/4-MP (n=36). Summarised data (inset) show
mean % depolarisation±SE for each application. (C) Progressive loss of
mitochondrial reduced nicotinamide adenine dinucleotide (phosphate)
(NAD(P)H) ﬂuorescence induced by ethanol/POA/4-MP (red, n=44) was
abolished by 3-BCP (cyan, n=36). Summarised data (inset) show
changes of NAD(P)H ﬂuorescence, expressed as mean±SE in
mitochondria-speciﬁc (mito) versus mitochondria-free (cytosolic; cyto)
regions, at baseline (70–100 s) and during stimulation (770–800 s)
(* and # p<0.05 compared to control).
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slowly developing, sustained component, indicating maintained
[Ca2+]C elevation. The ﬂuorescence rise was greatest in the
mitochondrial region (ﬁgure 3B,C), suggesting this was the
primary site of hydrolysis, with a smaller elevation in the baso-
lateral region, consistent with diffusion of ﬂuorescein. In cells
receiving POA-Fluor, NAD(P)H levels decreased as mitochon-
dria were inhibited, in contrast to adjacent cells which main-
tained their NAD(P)H (ﬁgure 3B).
Protective effects of 3-BCP on pancreatic acinar cell fate
Simultaneous detection of apoptotic and necrotic cell death
pathways in vitro showed that the NOME metabolite palmito-
leic acid ethyl ester (POAEE) (50–200 mM) signiﬁcantly
increased cell death (ﬁgure 4A); 200 mM POAEE increased
apoptosis from 0.4% (7/582 cells) to 10.8% (23/212 cells) and
necrosis from 10.8% (63/582 cells) to 41.5% (88/212 cells). In
contrast, application of acetaldehyde (100–200 mM) did not
increase either cell death pathway above non-treated controls
(ﬁgure 4A).
Ethanol (10 mM), POA (20 mM) and 4-MP (100 mM) alone
produced no signiﬁcant increases of either apoptotic or necrotic
cell death pathway activation above control values. In contrast, the
ethanol/POA/4-MP combination signiﬁcantly elevated overall cell
death: apoptotic cell death rose from 1.4% (16/1113 cells) to 9.5%
(90/952 cells) and necrotic cell death from 4.1% (45/1113 cells) to
25.3% (247/952 cells), respectively (ﬁgure 4B). In separate experi-
ments, application of ethanol/POA increased cell death, an effect
exacerbated by inhibition of OME with 4-MP (100 mM). The CEL
inhibitor 3-BCP (10 mM) signiﬁcantly protected against damage
induced by the ethanol/POA/4-MP combination (ﬁgure 4C).
Carboxylester lipase: localisation, formation of POAEE
and inhibition by 3-BCP
Immunoﬂuorescence showed predominantly apical, granular dis-
tribution of CEL in unstimulated isolated PACs and lobules
(ﬁgure 5A,B), consistent with prior observations.19 However,
CEL was redistributed into the luminal space between acinar clus-
ters in response to treatment with physiological cholecystokinin
(10 pM), consistent with secretion (ﬁgure 5B). Such redistribu-
tion into the lumen was also apparent in pancreatic lobules from
mice that received caerulein stimulation in vivo (see online sup-
plementary ﬁgure S2A). In contrast, widespread intragranular
and extragranular CEL distribution, throughout apical and baso-
lateral regions, was observed in pancreatic lobules from mice
treated with ethanol/POA to induce in vivo alcoholic AP (ﬁgure
5C). The translocation of CEL was observed in areas of tissue
damage in the FAEE-AP model as early as 15 min after induction
(see online supplementary ﬁgure S2C).
Computational docking studies indicated strong hydrogen
bonding interactions between Ser194 (Ser-OH:HO2C-POA; 2.75
Å) and His432 (His-N:HO2C-POA, 2.72Å) and the carboxylic
acid group of POA in the active site of CEL (ﬁgure 6A (i)).
Interaction of Ser194 with the carboxylic acid moiety of POA puts
it in close enough proximity (<4Å) for covalent reaction (via
mechanism-based esteriﬁcation) resulting in formation of a
Ser-POA complex (ﬁgure 6A (ii)). The Ser-POA complex can
readily react with ethanol to form POAEE (ﬁgure 6A (iii)).20
Docking results with the CEL inhibitor 3-BCP indicated that it
occupies a similar special position to the substrate allowing compe-
tition with POA for the active site (ﬁgure 6B (i)). 3-BCP is in close
proximity to Ser194 (hydrogen bonding between Ser-OH…
OCO-3-BCP; 2.66Å) and further stabilised by π-interactions (with
Trp227 and Phe324). Moreover, the Ser194 can react covalently
with 3-BCP via the C-Cl group (pathway A) or the lactone
carbonyl (pathway B) to form 3-BCP-enzyme complexes in a
mechanism-based inhibition/inactivation process (ﬁgure 6B (ii)).21
Conﬁrmation of the inhibitory action of 3-BCP on CEL was
shown via a concentration-dependent reduction of the rate of
Figure 4 Importance of non-oxidative metabolism of ethanol and
oxidative metabolism of ethanol in pancreatic acinar cell death.
(A) Levels of apoptosis (caspase; green) and necrosis (PI; red) were
increased by palmitoleic acid ethyl ester (POAEE;50–200 μmol/L)
compared with controls, whereas acetaldehyde (ACETAL,
100–200 μmol/L) was without effect. (B) Ethanol (EtOH; 10 mmol/L),
palmitoleic acid (POA;20 μmol/L) or 4-methylpyrazole (4-MP;100 μmol/
L), applied alone, did not increase caspase activation (green) or PI
uptake (red). However, a combination signiﬁcantly increased apoptotic
and necrotic cell death pathway activation. (C) Inhibition of
carboxylester lipase with 3-benzyl-6-chloro-2-pyrone (3-BCP;10 μmol/L)
reversed ethanol/POA-induced cell death precipitated by 4-MP
(expressed as % total cells; mean±SE; numbers in parentheses indicate
cells assessed for each experimental condition, *p<0.05 compared to
control values).
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p-nitrophenylacetate hydrolysis in isolated PACs (see online sup-
plementary ﬁgure S5C).
Protective effects of 3-BCP in a novel in vivo model
of alcoholic AP: FAEE-AP
The potential protective effects of 3-BCP were investigated in a
novel in vivo model of alcoholic AP. Intraperitoneal injections of
ethanol (1.35 g/kg), in combination with POA (0, 10, 20, 80
and 150 mg/kg), induced pancreatic damage observed in histo-
logical slices taken 24 h after application, with extensive acinar
cell oedema, neutrophil inﬁltration and necrosis apparent at 80
and 150 mg/kg (ﬁgure 7A). The combination of ethanol/POA
also elicited alveolar membrane thickening and inﬂammatory
inﬁltration of the lung but did not damage liver, kidney or heart
(ﬁgure 7B). Similarly, biochemical markers of AP, including
serum amylase, pancreatic trypsin and myeloperoxidase (MPO)
activity, were elevated in a dose-dependent manner by the
ethanol/POA combination (ﬁgure 7C (i–iii)). The time courses
of biochemical changes in the FAEE-AP model induced by
ethanol and POA are shown in online supplementary materials
and ﬁgure S3. In a similar manner, AP was induced by direct
intraperitoneal application of POAEE, thereby bypassing the
endogenous synthetic route or alternatively using oleic acid
instead of POA (see online supplementary ﬁgure S4).
Application of 3-BCP (30 mg/kg) signiﬁcantly reduced eleva-
tions of serum amylase, pancreatic trypsin activity and pancre-
atic MPO induced by ethanol/POA (ﬁgure 8A–D). Similarly, it
greatly ameliorated histopathological pancreatic damage induced
by ethanol/POA; overall histology score, acinar cell oedema,
neutrophil inﬁltration and necrosis were all signiﬁcantly reduced
by 3-BCP (ﬁgure 9A,B (i–iv)). In contrast, ethanol or POA alone
caused either a slight or no increase, respectively, in the overall
histopathology score (ﬁgure 9B (i)). The mild effect of ethanol
alone was due to small but signiﬁcant elevations of neutrophil
inﬁltration and oedema rather than acinar cell necrosis that
remained unaltered (ﬁgure 9B (ii–iv)). Concurrent inhibition of
OME by 4-MP, which by itself did not induce pancreatic
damage, caused signiﬁcantly greater PAC necrosis than that
Figure 5 Localisation of
carboxylester lipase (CEL) in pancreatic
acinar cells and lobules. (A)
Light-transmitted and ﬂuorescent
images of acinar cells showing CEL
(green) location in the apical granular
region, surrounded by peri-granular
mitochondria (mitochondrial
peptidyl-prolyl cis-trans isomerase:
red). Nuclei co-stained with Hoechst
33342 (blue). (B) Similar distribution of
CEL in unstimulated intact tissue.
Treatment with physiological
cholecystokinin (10 pM for 30 min)
caused CEL to redistribute into the
lumen between acinar clusters
suggestive of secretion. (C) A diffuse
intragranular and extragranular (apical
and basolateral) distribution of CEL
was observed in intact pancreatic
lobules obtained from mice treated
with ethanol/POA combination to
induce alcoholic acute pancreatitis (i.
p. ethanol (1.35 g/kg) and POA
(150 mg/kg)).
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induced by ethanol/POA alone (ﬁgure 9B (iv)); however, other
parameters of AP were not signiﬁcantly different (ﬁgures 8A–D
and 9B (ii–iii)).
An increase in POAEE was detected in the pancreas 30 min
after mice received ethanol/POA, which subsequently declined
during the following hours, whereas plasma POAEE remained
at control levels (see online supplementary ﬁgure S5A,B). The
elevation of FAEE levels in the pancreas was signiﬁcantly inhib-
ited by 3-BCP treatment (see online supplementary ﬁgure S5A).
The protective effects of 3-BCP were speciﬁc to FAEE-AP since
the CEL inhibitor did not ameliorate AP induced by caerulein
hyperstimulation (see online supplementary ﬁgure S6A–G).
DISCUSSION
This study has demonstrated the importance of NOME in mediat-
ing acute pancreatic toxicity and inﬂammation induced by alcohol,
damage arising primarily from Ca2+-dependent mitochondrial
dysfunction in PACs. Many theories have been proposed to
explain the detrimental effects of alcohol in AP,22 23 including
direct actions on Ca2+-release mechanisms,24 OME-sensitised
mitochondrial dysfunction25 and formation of toxic FAEEs.26 The
association between alcohol and fat in pancreatic damage is par-
ticularly intriguing; diets rich in corn oil and alcohol induce
chronic pancreatic injury in rats.24 Epidemiological studies suggest
that high fat diets may be linked to development of acute and
Figure 6 Proposed mechanism of fatty acid ethyl ester (FAEE) generation by carboxylester lipase (CEL) and inhibition by
3-benzyl-6-chloro-2-pyrone (3-BCP). (A) (i) Molecular docking interactions predict binding of palmitoleic acid (POA) in the active site of CEL via
interaction with Ser194 and His435 residues suggesting feasibility of mechanism-based esteriﬁcation. (ii) 2D representation of the binding mode of
POA in the active site indicates that the Ser194 hydroxyl group can react with the POA carbonyl group to afford a POA-Ser complex; ethanol easily
displaces Ser from the complex forming POA ethyl ester (POAEE). (iii) Mechanism-based esteriﬁcation of POA to POAEE. (B) (i) Binding of 3-BCP in
CEL active site indicates interaction with Ser194 (via hydrogen bonding), further stabilised by two π-interactions with Phe324 and Trp227. (ii)
Mechanism-based reaction of 3-BCP with Ser194 residue resulting in formation of 3-BCP-enzyme complex which is inhibitory for FAEE formation.
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chronic alcoholic pancreatitis,27 while hypertriglyceridaemia is an
independent risk factor for both.28 The present data highlight the
importance of NOME in mediating acute PAC damage leading to
AP. It is likely that under conditions of OME inhibition, available
alcohol and fatty acid from triglyceride hydrolysis are shunted
towards FAEE synthesis via NOME. In anaesthetised rats in which
OME was inhibited, the magnitude of FAEE production closely
correlated the concentration of ethanol injected intravenously,3
while plasma FAEE levels were raised in human subjects following
4-MP treatment.29 Diverse FAEEs, including the unsaturated ester
POAEE, are detectable in the serum of patients following ethanol
ingestion.9
Application of exogenous POAEE greatly increased PAC
death, while low level ethanol/POA, which did not cause
Figure 7 Features of fatty acid ethyl ester-induced acute pancreatitis induced by palmitoleic acid (POA)/ethanol. Mice received two intraperitoneal
injections of ethanol (1.35 g/kg) in combination with POA at 0, 10, 20, 80 and 150 mg/kg, and mice were sacriﬁced 24 h after ﬁrst injection.
(A) Representative H&E images of histology slides from pancreas of mice treated with ethanol with POA. (B) Ethanol with POA (150 mg/kg) caused
alveolar membrane thickening and inﬂammatory inﬁltration of the lung but did not induce any signiﬁcant damage to liver, kidney or heart. Effects
of ethanol with POA on (C) serum amylase, (D) Pancreatic trypsin activity and (E) Pancreatic myeloperoxidase activity (normalised). *p<0.05
compared to POA alone group. Values are mean±SE of 4–6 mice. Magniﬁcation: ×200.
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damage per se, became toxic when OME was inhibited. Since
this effect was sensitive to 3-BCP, the most likely explanation is
that FAEE generation via CEL was responsible for pancreatic
injury. Importantly, in vitro damage was reﬂected in pathological
changes in a novel murine model of alcoholic AP, a signiﬁcant
development in an area thus far lacking a convenient and reli-
able means of inducing this disease. Although the association
between alcohol and AP has long been recognised, our under-
standing of the underlying pathophysiology has been hampered
by lack of an appropriate experimental model; no reliable
model of AP has been made using application of ethanol
alone30 and other agents have been required, including chole-
cystokinin25 31 whose actions may be sensitised by alcohol.25 32
In the current study, intraperitoneal injections of ethanol/POA
to mice caused elevation of disease biochemical markers and
development of extensive pancreatic necrosis, neutrophil inﬁl-
tration and oedema. Such changes are consistent with acute
damage observed in rats by intra-arterial administration of
FAEEs26 or intravenous ethanol under conditions of OME
inhibition.3 In accord with in vitro ﬁndings, 3-BCP prevented
the increase of pancreatic POAEE in vivo and development of
AP induced by ethanol/POA, indicating that alcohol-induced
toxic effects are primarily mediated by FAEE production.
It has been suggested that OME may contribute to develop-
ment of alcoholic AP via oxidative stress. For example, acute
ethanol administration caused oxidative changes in rat pancre-
atic tissue,33 while high concentrations of acetaldehyde in vivo
damaged rat and dog pancreas.34 In contrast to the toxic effects
of POAEE, however, the OME metabolite acetaldehyde induced
no increase in PAC death. This supports previous observations
that acetaldehyde does not generate toxic Ca2+ elevations in
PACs12 and actually increased mitochondrial NAD(P)H (data
not shown) that would stimulate ATP production, consistent
with lack of toxicity. Furthermore, generation of reactive oxygen
species in exocrine pancreas may be protective, since this pro-
motes activation of apoptosis rather than necrosis.14 16
Important differences between NOME and OME have been
documented that support this view. For example, whereas
FAEEs activated NF-κB in PACs, acetaldehyde was inhibitory,1
while sustained elevation of acetaldehyde in ethanol-fed rats
prevented hepatic inﬂammation and necrosis.35
FAEEs are reported to exert many detrimental effects on PACs,
including premature activation of proteases and lipases capable of
digesting subcellular structures, effects which may involve IP3
receptor-mediated Ca2+ release from acidic stores36 and increased
fragility of lysosomes.37 Previously we have shown that toxic
Figure 8 Protective effects of 3-benzyl-6-chloro-2-pyrone (3-BCP) on biomarkers of fatty acid ethyl ester-induced acute pancreatitis (FAEE-AP)
induced by palmitoleic acid (POA)/ethanol. FAEE-AP was induced by two intraperitoneal injections of ethanol (1.35 g/kg) and POA (150 mg/kg). The
effects of inhibition of oxidative metabolism of ethanol (OME) with 4-methylpyrazole (4-MP; 10 mg/kg) or non-OME with 3-BCP (30 mg/kg), given
on the ﬁrst injection of POA/ethanol, were assessed on (A) Serum amylase, (B) Pancreatic trypsin activity, (C) Pancreatic myeloperoxidase activity
(normalised) and (D) Serum interleukin-6 (IL-6). Control mice received saline injections only. Mice were sacriﬁced 24 h after the ﬁrst injection.
*p<0.05 compared to both saline and POA controls, #p<0.05 compared to the POA/ethanol group. Values are mean±SE of 6 mice.
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Figure 9 Protective effects 3-benzyl-6-chloro-2-pyrone (3-BCP) on histological parameters of alcoholic acute pancreatitis. (A) Representative H&E
images of pancreas histology slides from treatment groups; combinations of ethanol (1.35 g/kg), palmitoleic acid (POA; 150 mg/kg),
4-methylpyrazole (4-MP; 10 mg/kg) and 3-BCP (30 mg/kg). (B)(i) Overall histopathological score and breakdown components: (ii) oedema,
(iii) inﬂammation and (iv) necrosis. All detrimental changes induced by ethanol/POA/4-MP were signiﬁcantly ameliorated by 3-BCP. (*p<0.05
compared to both saline and POA controls, #p<0.05 compared to ethanol/POA group. Values are mean±SE of 6 mice. Magniﬁcation: ×200).
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effects of FAEEs occur via Ca2+-dependent mitochondrial inhib-
ition leading to a fall of ATP and necrosis.13 38 39 In the present
study, blockade of OME transformed [Ca2+]C signals induced by
ethanol/POA from transient rises to toxic, sustained elevations and
potentiated mitochondrial inhibition. Growing evidence indicates
that mitochondrial dysfunction is a core pathological feature of
AP38 40 and an absence of a functional Na+/Ca2+ exchanger
renders the PAC critically dependent upon ATP levels for Ca2+
homeostasis. Thus FAEE-induced ATP depletion would arrest Ca2
+ extrusion via the plasmalemmal Ca2+-ATPase and reﬁlling of
internal stores via the sarco-endoplasmic reticulum Ca2+-ATPase,
resulting in elevated [Ca2+]C; Ca
2+ entry triggered by store deple-
tion would further exacerbate mitochondrial Ca2+ overload.
Here, use of a novel ﬂuorescent probe indicated that FAEEs dis-
tribute to mitochondria, where breakdown occurs releasing fatty
acids. This is in accord with biochemical measurements in cardio-
myocytes, which demonstrated that >70% of FAEEs bound pref-
erentially to mitochondria and underwent hydrolysis.18 Such
FAEE hydrolytic activity has been demonstrated in the human pan-
creas,41 although the identity of the mitochondrial enzyme(s)
responsible has yet to be clariﬁed. Free fatty acids induce sustained
[Ca2+]C elevations and necrosis of PACs
12 42 and are known to
uncouple mitochondria at concentrations as low as 5 mM.18 43 44
In the present study, hydrolysis of POA-Fluor was associated with
sustained elevation of [Ca2+]C and loss of NAD(P)H, consistent
with mitochondrial inhibition as fatty acids are released.
Diverse enzymes can synthesise FAEEs, collectively known as
FAEE synthases, including CEL, triglyceride lipase, lipoprotein
lipase and acyl-coenzymeA:ethanolO-acyltransferase.4 These are
poorly characterised, although the gene structure and cDNA
sequence of human CEL has been elucidated45 with high enzyme
expression reported in pancreas.46 47 Immunoﬂuorescence
detected CEL in the granular, apical area of PACs under basal con-
ditions. However, stimulation with cholecystokinin in vitro or
caerulein in vivo redistributed the enzyme to the luminal area in
pancreatic lobes, consistent with secretion. CEL enters the secre-
tory pathway, and in adult humans, comprises approximately 4%
of protein in pancreatic juice.48 However, pancreatic damage can
release CEL into the blood49 with increased levels reported in
patients with acute interstitial or necrotising pancreatitis, leading
to the proposition that CEL may constitute a sensitive marker of
AP severity.11 Furthermore, CEL redistributed outside of zymogen
granules into the cytosolic compartment of necrotic PACs, with
intense staining found around necrotic pancreatic lobules and in
areas of fat necrosis in AP.19 In accord, in pancreatic lobules from
mice treated with ethanol/POA in vivo, there was a diffuse intra-
granular and extragranular distribution of CEL throughout the
PACs, apparent in damaged areas as early as 15 min after applica-
tion of ethanol/POA. In an alcohol-rich and fatty acid–rich envir-
onment, localised elevation of CEL would enhance production of
FAEEs capable of causing extensive tissue damage. In acutely
intoxicated patients, FAEEs may attain levels as high as 115 mM/
L,2 concentrations shown in the present study to elicit signiﬁcant
cellular necrosis.
Importantly, the damaging effects of ethanol and fat induced
by promotion of NOME, both in vitro and in vivo, were signiﬁ-
cantly ameliorated by inhibition of CEL with 3-BCP, an agent
previously shown to inhibit FAEE production and toxicity in
cultured AR42J cells6, and now in pancreas. Although the
inhibitory action of 3-BCP has been previously documented, use
of molecular modelling has now demonstrated its likely mechan-
ism of action. Structural analysis indicates stable binding of
3-BCP into the active site of CEL, via interaction with a Ser194
residue, that would compete with fatty acids and thus inhibit
ethanol-mediated fatty acid esteriﬁcation required for toxic
FAEE generation. Identiﬁcation of critical binding features sug-
gests that rational design of speciﬁc modulators of CEL to block
FAEE production is feasible, and candidate drugs may now be
tested using a convenient and reliable model of alcoholic AP.
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